Influence of psychotherapy attendance on buprenorphine treatment outcome. - Wikidata - awgldk - TriplyDB

Influence of psychotherapy attendance on buprenorphine treatment outcome.

Influence of psychotherapy attendance on buprenorphine treatment outcome.

http://www.wikidata.org/entity/Q37079329

about

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.Narrative review: buprenorphine for opioid-dependent patients in office practice.Feedback versus no feedback in improving patient outcome in group psychotherapy for eating disorders (F-EAT): protocol for a randomized clinical trial.Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review.The dynamic interaction between pain and opioid misuse.The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program.Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance.Buprenorphine treatment: factors and first-hand experiences for providers to consider.Emerging Evidence for Cannabis' Role in Opioid Use Disorder

P2860

Q24235930-97C77FC2-8986-4251-84BF-08C7C205E812 Q24241043-94DF1B70-80C8-468E-BC04-8E321D2F8E3F Q33740800-7A581F1E-50C2-4421-805B-7D2E57230147 Q36508384-A63579B4-4093-41A7-A867-02CC81CA8A5D Q36959052-E88E9D9E-CEF9-4CDA-B402-04A5F6E23990 Q37733802-BABB3767-4309-4F5B-BD46-5A51C4D452AA Q38691415-4BB8F66D-4B0D-4022-BFB4-7A7A5B05F129 Q38731968-D9C76783-CD67-4821-90DF-5648BCEA7704 Q39039330-354B37B8-DFEE-4E3A-AC36-FD9715479447 Q41367554-F1CCBB5A-2515-457A-A333-EC3FAB62B34E Q43213065-0E9DDE5C-C618-4B94-B503-92ECBF44A707 Q51904834-C45BA465-586F-45A8-BDAC-9288A4292028 Q58775143-4D2AFFA1-25F0-4BF3-B71B-F1424AC831EE

P2860

Influence of psychotherapy attendance on buprenorphine treatment outcome.

http://www.wikidata.org/entity/Q37079329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@en

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@nl

type

label

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@en

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@nl

prefLabel

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@en

Influence of psychotherapy attendance on buprenorphine treatment outcome.

@nl

P1433

Q37079329-46E87F20-8E10-4401-BDD5-4C7CB6B3F714

P1476

Q37079329-B4EA063A-BC89-4196-96A0-F2EE307D5BC9

P2093

Q37079329-03C3167A-6CE3-4901-BFFF-523294779974

Q37079329-058ECA6D-D11F-4B83-9990-038CDD2B5EB5

Q37079329-311AE008-8B85-4886-A0F3-3AB73CF3657E

Q37079329-681146A8-11F0-4255-8993-40AEF6826758

Q37079329-808E923E-8CA9-4FE6-A0F1-2E4498906A4E

Q37079329-8E515903-CE07-4EB6-B2AA-DE74C09EDFBB

Q37079329-D53EC724-CA00-44D5-B55F-E6A16C458334

Q37079329-DE8BB457-670A-4B23-BACA-4718D5271713

P2860

Q37079329-0437D3D6-31A8-4040-9BA4-707640EF9878

Q37079329-07F056FA-45A3-4A10-B1F1-6DED80B94B43

Q37079329-12E71B69-1AB1-449C-8D79-F83E3EDD6A47

Q37079329-18C46632-D44B-47F6-9506-61BF418F97AD

Q37079329-25CF1F00-B747-4645-932E-05CC00E53954

Q37079329-25F86FFF-EC48-4DA8-9067-778DAF16FB41

Q37079329-2DA4F7BB-850C-480E-BC04-DB6F4521540E

Q37079329-2F744F4A-EAFF-4ACD-9002-4A0A8DAD17E5

Q37079329-32782830-68EC-457B-AB1A-E6F2D6ADF19F

Q37079329-3331D0FC-1911-4EBB-82EB-A07F2ADBE1ED

P304

Q37079329-3145661F-B42F-4EFC-8799-2CE44F554D63

P31

Q37079329-748CAED9-A4D3-4F27-A5F8-F5E6CE66CFE6

P356

Q37079329-959C6D15-A276-4F11-A400-79AE75DCE22C

P433

Q37079329-D69113D3-E343-40A9-9159-9A11552C1088

P478

Q37079329-804A8888-6A5A-4635-8907-E4DB47F93BE6

P50

Q37079329-13C99EF1-8665-40A6-B215-0BFC3FD5DD3D

P577

Q37079329-4BFBD614-4C38-4562-8C74-58B9D811A22E

P5875

Q37079329-2B0D2031-31B0-4FB2-8A66-FFFC37D1176B

P698

Q37079329-EBB5B9B6-2CC8-4BFE-98FD-6EBE3C0AD0F1

P932

Q37079329-83E7FD06-0BB9-47BB-8A60-3A171AF80F88

P356

J.JSAT.2005.01.004

P1433

Journal of Substance Abuse Treatment

P1476

Influence of psychotherapy attendance on buprenorphine treatment outcome

@en

P2093

Annie Umbricht

http://www.w3.org/2001/XMLSchema#string

Carlo Contoreggi

http://www.w3.org/2001/XMLSchema#string

David A Gorelick

http://www.w3.org/2001/XMLSchema#string

Iván D Montoya

http://www.w3.org/2001/XMLSchema#string

Jennifer R Schroeder

http://www.w3.org/2001/XMLSchema#string

Lino Covi

http://www.w3.org/2001/XMLSchema#string

Paul J Fudala

http://www.w3.org/2001/XMLSchema#string

Rolley E Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance

Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Why extensive participation in treatment and twelve-step programs is associated with the cessation of addictive behaviors: an application of the addicted-self model of recovery.

Treatment non-adherence in affective disorders.

Recent advances in the dissemination of contingency management techniques: clinical and research perspectives.

Voucher-based incentives. A substance abuse treatment innovation.

Understanding polydrug use: review of heroin and cocaine co-use.

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence

A model for pharmacological research-treatment of cocaine dependence.

Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings.

P304

247-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSAT.2005.01.004

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Kenzie L. Preston

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7879827

http://www.w3.org/2001/XMLSchema#string

P698

15857725

http://www.w3.org/2001/XMLSchema#string

P932

2633651

http://www.w3.org/2001/XMLSchema#string